NCT04490772

Brief Summary

Patients confirmed COVID-19 with gastrointestinal manifestations will be included. Characteristics and outcomes will be described for them.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2020

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

July 20, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 29, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

July 29, 2020

Status Verified

July 1, 2020

Enrollment Period

2 months

First QC Date

July 20, 2020

Last Update Submit

July 27, 2020

Conditions

Infectious

Keywords

Covid-19characteristicsOutcomeEgypt

Outcome Measures

Primary Outcomes (3)

  • Clinical data questionnaire

    Clinical characteristics of age, sex, comorbidities and symptoms.

    2 months

  • Tests such as CBC

    Laboratory characters

    2 months

  • liver function test

    Laboratory characters

    2 months

Study Arms (1)

Patients with Covid-19

COVID-19 patients presented with gastrointestinal manifestations

Diagnostic Test: Laboratory tests

Interventions

Laboratory testsDIAGNOSTIC_TEST

Laboratory tests such as CBC, Liver function and CRP

Patients with Covid-19

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Confirmed Covid-19 with GIT manifestations

You may qualify if:

  • Confirmed Covid-19 with GIT manifestations

You may not qualify if:

  • Patients refuse to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Communicable DiseasesCOVID-19

Interventions

Clinical Laboratory Techniques

Condition Hierarchy (Ancestors)

InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsPneumonia, ViralPneumoniaRespiratory Tract InfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Tropical Medicine and Gastroenterology

Study Record Dates

First Submitted

July 20, 2020

First Posted

July 29, 2020

Study Start

July 1, 2020

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

July 29, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share